Concepedia

Yasutaka Miyachi

YM

Statistics

Publications

14

Citations

812

H-Index

12

Active since

1986

Affiliations

Japan Agency for Medical Research and Development(Current)

Kyushu University

Tokyo Medical and Dental University

University of Yamanashi

Nagoya University

Yasutaka Miyachi is an author at Japan Agency for Medical Research and Development specializing in medicine, pharmacology, and metabolic regulation.

ORCID

Publications per year

1986–2023

14

Publications

14

Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction

Chikara Komiya, Kyoichiro Tsuchiya, Kumiko Shiba et al. · PLoS ONE · 2016 · 229 citations · Full text

, , +17

Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH

Kumiko Shiba, Kyoichiro Tsuchiya, Chikara Komiya et al. · Scientific Reports · 2018 · 175 citations · Full text

, , +17

Roles for Cell-Cell Adhesion and Contact in Obesity-Induced Hepatic Myeloid Cell Accumulation and Glucose Intolerance

Yasutaka Miyachi, Kyoichiro Tsuchiya, Chikara Komiya et al. · Cell Reports · 2017 · 72 citations · Full text

, , +17

Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis

Chikara Komiya, Miyako Tanaka, Kyoichiro Tsuchiya et al. · Scientific Reports · 2017 · 64 citations · Full text

, , +16

A reduced M1-like/M2-like ratio of macrophages in healthy adipose tissue expansion during SGLT2 inhibition

Yasutaka Miyachi, Kyoichiro Tsuchiya, Kumiko Shiba et al. · Scientific Reports · 2018 · 58 citations · Full text

, , +17

1–5 of 14